1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI).
Saved in:
| Title: | 1152P Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI). |
|---|---|
| Authors: | Costa Svedman, F.1 (AUTHOR), Liapi, M.2 (AUTHOR), Chatzidionysiou, A.2 (AUTHOR), Månsson-Broberg, A.3 (AUTHOR), Egyhazi Brage, S.4 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS688-S689. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.2286 |
